SEC Form 4 · accession 0000899243-19-006926
CONSTELLATION PHARMACEUTICALS INC · CNST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Adrian Senderowicz
Officer — Chief Medical Officer
Period of report
Mar 7, 2019
Accepted (ET)
Mar 8, 2019 · 4:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434418
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $8.76 | Mar 7, 2019 | A | 93,000 | A | — | Mar 6, 2029 | Common Stock | 93,000 | 93,000 | D |
Explanation of responses
- F1This option was granted on March 7, 2019, and the shares underlying the option vest in equal quarterly installments through March 7, 2023, subject to continued service.